Targeting of nuclear Factor-κB and proteasome by dithiocarbamate complexes with metals

被引:122
作者
Cvek, B. [1 ]
Dvorak, Z. [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic
关键词
disulfiram; diethyldithiocarbamate (DDTC); pyrrolidinedithiocarbamate (PDTC); metal dithiocarbamates; NF-kappa B; proteasome; JAMM;
D O I
10.2174/138161207782110390
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dithiocarbamates and their complexes with transition metals have been used as common pesticides, vulcanizing or analytical agents for decades. These compounds are one of the most reported inhibitors of nuclear factor-kappa B (NF-kappa B) signaling cascade. Recently, it has been found that dithiocarbamates are very potent inhibitors of proteasome. NF-kappa B plays a central role in the immune system and is described as major actor in many of human cancers mainly because of its protective effects against apoptosis. Molecular mechanisms involved in regulation and function of NF-kappa B pathway have been elucidated recently. In particular, pivotal zinc containing proteins that alter NF-kappa B signal transduction were recognized, Additionally, proteasome system was found to be a key player in NF-kappa B pathway and is an attractive target for anticancer drug development Collectively, the capability of dithiocarbamates to inhibit NF-kappa B and proteasome makes these compounds promising anticancer agents. This review focuses on the biological activity of dithiocarbamate coordination compounds with regard to their possible molecular targets in NF-kappa B signaling and proteasome (JAMM domain proteins). Future research should aim to find the most suitable dithiocarbamate coordination compounds for treatment of cancer and other diseases.
引用
收藏
页码:3155 / 3167
页数:13
相关论文
共 348 条
  • [1] AASETH J, 1979, ACTA PHARMACOL TOX, V45, P41
  • [2] ALTERNATIVE THERAPIES IN HIV-INFECTION
    ABRAMS, DI
    [J]. AIDS, 1990, 4 (12) : 1179 - 1187
  • [3] The proteasome: A suitable antineoplastic target
    Adams, J
    [J]. NATURE REVIEWS CANCER, 2004, 4 (05) : 349 - 360
  • [4] The development of proteasome inhibitors as anticancer drugs
    Adams, J
    [J]. CANCER CELL, 2004, 5 (05) : 417 - 421
  • [5] Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells
    Adsule, Shreelekha
    Barve, Vivek
    Chen, Di
    Ahmed, Fakhara
    Dou, Q. Ping
    Padhye, Subhash
    Sarkar, Fazlul H.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 7242 - 7246
  • [6] Nuclear factor-κ-B:: The enemy within
    Aggarwal, BB
    [J]. CANCER CELL, 2004, 6 (03) : 203 - 208
  • [7] DIETHYLDITHIOCARBAMATE, COPPER AND NEUROLOGICAL DISORDERS
    ALLAIN, P
    KRARI, N
    [J]. LIFE SCIENCES, 1991, 48 (03) : 291 - 299
  • [8] ALLAIN P, 1993, RES COMMUN CHEM PATH, V80, P105
  • [9] JAMM: A metalloprotease-like zinc site in the proteasome and signalosome
    Ambroggio, XI
    Rees, DC
    Deshaies, RJ
    [J]. PLOS BIOLOGY, 2004, 2 (01) : 113 - 119
  • [10] Effect of neurotoxic metal ions on the proteolytic activities of the 20S proteasome from bovine brain
    Amici, M
    Forti, K
    Nobili, C
    Lupidi, G
    Angeletti, M
    Fioretti, E
    Eleuteri, AM
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2002, 7 (7-8): : 750 - 756